Literature DB >> 21037491

Acetaminophen inhibits status epilepticus in cultured hippocampal neurons.

Laxmikant S Deshpande1, Robert J DeLorenzo.   

Abstract

Status epilepticus (SE) is a major neurological disorder and SE survivors often develop acquired epilepsy and cognitive deficits. Thus, it is important to stop SE and limit brain damage. However, rapid pharmacoresistance develops to anticonvulsants as seizure duration lengthens. Recently, acetaminophen was reported to increase endocannabinoid levels by its conversion to AM 404. Further, cannabinoids are potent anticonvulsants. Here we investigated whether acetaminophen would block SE-like activity in hippocampal neurons. Exposure of cultured hippocampal neurons to a low Mg2+ medium elicits high-frequency epileptiform discharges that exceed 3 Hz (in-vitro SE). Acetaminophen (500 μM) blocks the SE-like activity. CB1 receptor antagonist SR 141716A (1 μM) blocked this inhibitory effect of acetaminophen on SE, indicating that acetaminophen was mediating its anticonvulsant effects through CB1 receptors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21037491      PMCID: PMC3052417          DOI: 10.1097/WNR.0b013e3283413231

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  25 in total

Review 1.  Status epilepticus.

Authors:  D H Lowenstein; B K Alldredge
Journal:  N Engl J Med       Date:  1998-04-02       Impact factor: 91.245

2.  Development of low magnesium-induced spontaneous synchronized bursting and GABAergic modulation in cultured rat neocortical neurons.

Authors:  S Watanabe; Y Jimbo; H Kamioka; Y Kirino; A Kawana
Journal:  Neurosci Lett       Date:  1996-05-24       Impact factor: 3.046

Review 3.  Cellular mechanisms underlying acquired epilepsy: the calcium hypothesis of the induction and maintainance of epilepsy.

Authors:  Robert J Delorenzo; David A Sun; Laxmikant S Deshpande
Journal:  Pharmacol Ther       Date:  2004-12-09       Impact factor: 12.310

4.  A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group.

Authors:  D M Treiman; P D Meyers; N Y Walton; J F Collins; C Colling; A J Rowan; A Handforth; E Faught; V P Calabrese; B M Uthman; R E Ramsay; M B Mamdani
Journal:  N Engl J Med       Date:  1998-09-17       Impact factor: 91.245

5.  Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404.

Authors:  A Giuffrida; F Rodriguez de Fonseca; F Nava; P Loubet-Lescoulié; D Piomelli
Journal:  Eur J Pharmacol       Date:  2000-11-17       Impact factor: 4.432

6.  Status epilepticus increases the intracellular accumulation of GABAA receptors.

Authors:  Howard P Goodkin; Jwu-Lai Yeh; Jaideep Kapur
Journal:  J Neurosci       Date:  2005-06-08       Impact factor: 6.167

7.  A role for endocannabinoids in viral-induced dyskinetic and convulsive phenomena.

Authors:  Marylou V Solbrig; Russell Adrian; Janie Baratta; Daniele Piomelli; Andrea Giuffrida
Journal:  Exp Neurol       Date:  2005-08       Impact factor: 5.330

8.  Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects.

Authors:  M J Wallace; J L Wiley; B R Martin; R J DeLorenzo
Journal:  Eur J Pharmacol       Date:  2001-09-28       Impact factor: 4.432

9.  Effect of non-steroidal anti-inflammatory drugs on the anticonvulsive activity of valproate and diphenylhydantoin against maximal electroshock-induced seizures in mice.

Authors:  R Kaminski; M Kozicka; J Parada-turska; M Dziki; Z Kleinrok; W A Turski; S J Czuczwar
Journal:  Pharmacol Res       Date:  1998-05       Impact factor: 7.658

10.  The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy.

Authors:  Melisa J Wallace; Robert E Blair; Katherine W Falenski; Billy R Martin; Robert J DeLorenzo
Journal:  J Pharmacol Exp Ther       Date:  2003-09-03       Impact factor: 4.030

View more
  6 in total

1.  Validation of a Preclinical Drug Screening Platform for Pharmacoresistant Epilepsy.

Authors:  Melissa L Barker-Haliski; Kristina Johnson; Peggy Billingsley; Jennifer Huff; Laura J Handy; Rizvana Khaleel; Zhenmei Lu; Matthew J Mau; Timothy H Pruess; Carlos Rueda; Gerald Saunders; Tristan K Underwood; Fabiola Vanegas; Misty D Smith; Peter J West; Karen S Wilcox
Journal:  Neurochem Res       Date:  2017-03-16       Impact factor: 3.996

2.  Upregulation of RBFOX1 in the malformed cortex of patients with intractable epilepsy and in cultured rat neurons.

Authors:  Ming Wen; Yong Yan; Ning Yan; Xiao Shan Chen; Shi Yong Liu; Zhan Hui Feng
Journal:  Int J Mol Med       Date:  2015-01-05       Impact factor: 4.101

3.  Paracetamol sharpens reflection and spatial memory: a double-blind randomized controlled study in healthy volunteers.

Authors:  Gisèle Pickering; Nicolas Macian; Claude Dubray; Bruno Pereira
Journal:  Drug Des Devel Ther       Date:  2016-12-05       Impact factor: 4.162

Review 4.  A Guide to Targeting the Endocannabinoid System in Drug Design.

Authors:  Adam Stasiulewicz; Katarzyna Znajdek; Monika Grudzień; Tomasz Pawiński; And Joanna I Sulkowska
Journal:  Int J Mol Sci       Date:  2020-04-16       Impact factor: 5.923

5.  Pharmacological induction of AMFR increases functional EAAT2 oligomer levels and reduces epileptic seizures in mice.

Authors:  Longze Sha; Guanjun Li; Xiuneng Zhang; Yarong Lin; Yunjie Qiu; Yu Deng; Wanwan Zhu; Qi Xu
Journal:  JCI Insight       Date:  2022-08-08

6.  Orexin Receptor Multimerization versus Functional Interactions: Neuropharmacological Implications for Opioid and Cannabinoid Signalling and Pharmacogenetics.

Authors:  Miles D Thompson; Takeshi Sakurai; Innocenzo Rainero; Mary C Maj; Jyrki P Kukkonen
Journal:  Pharmaceuticals (Basel)       Date:  2017-10-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.